25-hydroxyvitamin D levels are inversely related to metabolic syndrome risk profile in northern Chinese subjects without vitamin D supplementation

• Published in: Diabetology and metabolic syndrome Vol. 14; no. 1; p. 23
• Main Authors: Xu, Hanyuan, Han, Guiyan, Wang, Linjie, Ding, Huihua, Wang, Chunyan, Ping, Xiaochuan, Dong, Caixia, Zhang, Dianxi, Dai, Yufei, Li, Naishi, Li, Yufeng, Yang, Hongbo, Zhu, Huijuan, Pan, Hui, Gong, Fengying, Chen, Jichun, Xing, Xiaoping
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 29.01.2022; BioMed Central; BMC
• Subjects: 25-Hydroxyvitamin D; 25-hydroxyvitamin D [25(OH)D]; Alfacalcidol; Blood pressure; Blood sugar; Calcifediol; Calories; Cholesterol; Counseling; Cross-sectional study; Diabetes; Diet; Dietary supplements; Glucose; High density lipoprotein; Homeostasis; Insulin resistance; Laboratories; Lipoproteins; Longitudinal study; Low density lipoprotein; Low density lipoproteins; Metabolic indices; Metabolic syndrome; Metabolic syndrome (MetS); Metabolites; Obesity; Patients; Telmisartan; Triglycerides; Type 2 diabetes; Vitamin D; Vitamin deficiency; China; Beijing China; Metabolic syndrome (MetS); Cross-sectional study; 25-hydroxyvitamin D [25(OH)D]; Metabolic indices; Longitudinal study
• ISSN: 1758-5996; 1758-5996
• DOI: 10.1186/s13098-022-00793-1

The comparatively low 25 hydroxyvitamin D [25(OH)D] levels have been reported in patients with metabolic syndrome (MetS). Herein we investigated the cross-sectional and longitudinal relationships between serum 25(OH)D levels and MetS risk profile in northern middle-aged Chinese subjects without vitamin D supplementation. A cohort of 211 participants including 151 MetS patients and 60 controls at 20-69 years of age were enrolled from suburban Beijing, China. The recruited MetS patients were subjected to diet and exercise counselling for 1-year. All subjects at baseline and MetS patients after intervention underwent clinical evaluations. Serum 25(OH)D levels were significantly decreased in MetS patients. 25(OH)D levels were inversely related to MetS score, fasting blood glucose (FBG) and triglyceride-glucose index (TyG) after adjusting for cofounders (all P < 0.05). Participants in the lowest tertile of 25(OH)D levels had increased odds for MetS (P = 0.045), elevated FBG (P = 0.004) in all subjects, and one MetS score gain in MetS patients (P = 0.005). Longitudinally, the metabolic statuses as well as 25(OH)D levels of MetS patients were significantly improved (all P < 0.05), and the increase of 25(OH)D levels were inversely related to MetS scores, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), FBG, and TyG, while positively related to high-density lipoprotein cholesterol (HDL-C) after adjusting for confounders. 25(OH)D levels were significantly decreased in MetS patients, and it was negatively associated with metabolic dysfunctions at baseline and 1-year after. Metabolic aberrations of MetS patients were significantly ameliorated with 1-year follow-up counselling accompanying by notably elevated 25(OH)D levels.